In aspirin-exacerbated respiratory disease, CysLT2R signaling on platelets could use RAGE/HMGB1 as a link to the downstream type 2 respiratory immunopathology and IL-33-dependent mast cell activation typical of aspirin-exacerbated respiratory disease [31]. Here, IL33 is linked to respiratory system disorder.